| N0 (N=249) |
N1_N2 (N=170) |
P-value | |
|---|---|---|---|
| pathologic_T | |||
| T2 | 249 (100%) | 170 (100%) | <0.001 |
| pathologic_M | |||
| M0 | 177 (71.1%) | 134 (78.8%) | 0.187 |
| M1 | 8 (3.2%) | 3 (1.8%) | |
| MX | 64 (25.7%) | 33 (19.4%) | |
| pathologic_stage | |||
| Stage I | 206 (82.7%) | 0 (0%) | <0.001 |
| Stage II | 34 (13.7%) | 110 (64.7%) | |
| Stage IV | 8 (3.2%) | 3 (1.8%) | |
| Stage III | 0 (0%) | 55 (32.4%) | |
| Missing | 1 (0.4%) | 2 (1.2%) | |
| Age (years) | |||
| Mean (SD) | 66.4 (10.1) | 65.1 (9.46) | 0.252 |
| Median [Min, Max] | 68.0 [33.0, 87.0] | 65.5 [41.0, 87.0] | |
| Missing | 12 (4.8%) | 8 (4.7%) | |
| gender | |||
| FEMALE | 91 (36.5%) | 64 (37.6%) | 0.9 |
| MALE | 158 (63.5%) | 106 (62.4%) |